COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,387 Articles (22,816 medRxiv, 8,571 bioRxiv)

Most recent first Previous |  Page 2308: Articles 23071-23080  | Next

Comparative performance of five commercially available serologic assays to detect antibodies to SARS-CoV-2 and identify individuals with high neutralizing titers
Patel, E., Bloch, E. M., Clarke, W., Hsieh, Y.-H., Boon, D., Eby, Y. J., Fernandez, R. E., Baker, O. R., Keruly, M., Kirby, C. S., Klock, E., Littlefield, K., Miller, J., Schmidt, H. A., Sullivan, P., Piwowar-Manning, E., Shrestha, R., Redd, A. D., Rothman, R. E., Sullivan, D. J., Shoham, S., Casadevall, A., Quinn, T. C., Pekosz, A., Tobian, A. A., Laeyendecker, O.
10.1101/2020.08.31.20184788 — Posted: 2020-09-02
Asymptomatic cases and limited transmission of SARS-CoV-2 in residents and healthcare workers in three Dutch nursing homes
van Buul, L. W., van den Besselaar, J. H., Koene, F. M. H. P. H., Buurman, B. M., Hertogh, C. M. P. M.
10.1101/2020.08.31.20185033 — Posted: 2020-09-02
Health and economic effects of COVID-19 control in Australia: Modelling and quantifying the payoffs of hard versus soft lockdown
Grafton, Q., Kompas, T., Parslow, J., Glass, K., Banks, E., Lokuge, K.
10.1101/2020.08.31.20185587 — Posted: 2020-09-02
First snap-shot meta-analysis to estimate the prevalence of serum antibodies to SARS-CoV-2 in humans
Rostami, A., Sepidarkish, M., Leeflang, M., Riahi, S. M., Nourollahpour Shiadeh, M., Esfandyari, S., Mokdad, A. H., Hotez, P. J., Gasser, R. B.
10.1101/2020.08.31.20185017 — Posted: 2020-09-02
A neutrophil activation signature predicts critical illness and mortality in COVID-19
Meizlish, M. L., Pine, A. B., Bishai, J. D., Goshua, G., Nadelmann, E. R., Simonov, M., Chang, C.-H., Zhang, H., Shallow, M., Bahel, P., Owusu, K., Yamamoto, Y., Arora, T., Atri, D. S., Patel, A., Gbyli, R., Kwan, J., Won, C. H., Dela Cruz, C., Price, C., Koff, J., King, B. A., Rinder, H. M., Wilson, F. P., Hwa, J., Halene, S., Damsky, W., van Dijk, D., Lee, A. I., Chun, H.
10.1101/2020.09.01.20183897 — Posted: 2020-09-02
A comprehensive analysis of recovered COVID-19 patients and dynamic trend in antibodies over 3 months using ELISA and CLIA methods.
Dehgani-Mobaraki, P., Kamber Zaidi, A., Floridi, A., Lepri, A., Floridi, E., Gherardi, A., Bernini-Carri, E., Durzo, E., Dehgani-Mobaraki, M.
10.1101/2020.08.31.20184838 — Posted: 2020-09-02 Discussion: Offsite
COVID-19 Detection From Chest Radiographs Using Machine Learning and Convolutional Neural Networks
Li, A. C., Lee, D. T., Misquitta, K. K., Uno, K., Wald, S.
10.1101/2020.08.31.20175828 — Posted: 2020-09-02
PREDICTIVE VALUE OF SMELL AND TASTE TEST VS PCR-RT SARS-COV-2 AND RAPID DIAGNOSTIC TESTS IN THE DIAGNOSIS OF INFECTION BY COVID-19. A PROSPECTIVE MULTI-CENTRIC STUDY.
Pieruzzini, R., Ayala, C., Navas, J., Rodriguez, W. C., Parra, N., Luque, E., Sanchez, A., Gonzalez, S., Hagobian, A., Grullon, A., Diaz, K., Morales, M., De Jesus, M., Pena, S., Rodriguez, L., Pena, L., Asaro, A., Magris, M.
10.1101/2020.08.31.20185298 — Posted: 2020-09-02
Suicide during the COVID-19 pandemic in Japan
Tanaka, T., Okamoto, S.
10.1101/2020.08.30.20184168 — Posted: 2020-09-02
Dealing with Covid-19 infections in Kolkata, India: A GIS based risk analysis and implications for future scenarios
Nath, B., Majumder, S., Rahman, M. M., Sen, J.
10.1101/2020.08.31.20185215 — Posted: 2020-09-02

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).